Veterinary Diagnostics, Pet Insurance and Payment After the Exam

|13 min read
Female veterinarian sitting with client in exam room discussing results of the client's dog treatment, the dog lays on the floor with a cone on it's head and a bandage on it's leg.

Theme this week

Post-exam is where practice revenue is captured or lost. Every handoff step carries real financial consequence, from diagnostic routing and client payment to entering medical notes and charge coding. Strengthen test routing, direct pay workflows, payment scripts, heart check protocols, and revenue mapping before small gaps become larger losses.

New to PULSE? Start here to get more out of PULSE intelligence briefs.

Executive takeaways

  1. Track tests completed per visit this month. IDEXX’s Q1 Companion Animal Group growth and 1,100 inVue Dx devices-placed make in clinic testing a workflow to review. 1
  2. Review insurance direct pay steps this month. Trupanion’s subscription revenue growth and 1,105,783 subscription enrolled pets may make claim steps more visible during treatment approval. 2
  3. Track declined care cases weekly. PetSmart Charities’ access-to-care grants and payment plan pilot keep cost pressure at checkout. 3
  4. Review canine heart check workflow this month. Boehringer Ingelheim and Eko’s AI murmur tool adds decision support software to routine exams. 4
  5. Map revenue and expense categories this month. VMG and AAHA’s updated Chart of Accounts gives practices a clearer structure for reporting and benchmarking. 5

Signals

1. IDEXX growth puts more testing inside the clinic

OBSERVED

IDEXX reported Q1 2026 revenue of $1.141 billion on May 5, 2026, up 14% as reported and 11% using IDEXX’s company adjusted organic growth measure. Companion Animal Group revenue grew 15% as reported and 12% organic. IDEXX also reported 33% reported growth and 28% organic growth in Companion Animal Group revenue from diagnostics instrument, including 1,100 IDEXX inVue Dx devices placed. 1

VIEWPOINT

This strengthens where testing is run and billed inside the clinic. More IDEXX devices in clinics may increase the share of tests run on IDEXX equipment and supplies.

The pressure point is tests completed per visit. Clinics and groups should measure whether testing stays inside the practice, moves to an outside lab, or gets deferred when visit volume slows.

CONFIDENCE

High — supported by an official company earnings release; clinic level uptake and competitor response remain open.

ACTIONS

Independent veterinary practices

  • Review in-clinic diagnostics volume this month.
  • Track test acceptance by visit type weekly.

Corporate veterinary groups and clinic consolidators

  • Compare diagnostics use by region this month.
  • Track cost and return from new instruments quarterly.

Distributors, e-retail and home delivery providers

  • Watch demand for diagnostics supplies this quarter.
  • Track clinic partner requests for testing supplies monthly.

Manufacturers and commercial operators

  • Review diagnostics comparison materials this month.
  • Track clinic accounts likely to compare vendors before the next sales call cycle.

2. Trupanion growth puts insurance steps at checkout

OBSERVED

Trupanion reported Q1 2026 total revenue of $384.0 million on April 30, 2026, up 12% from Q1 2025. Subscription revenue was $269.5 million, up 16%. Subscription enrolled pets reached 1,105,783 at March 31, 2026. Trupanion also said its patented process can pay veterinarians directly at checkout. 2

VIEWPOINT

This is a signal about how clients pay for recommended care at checkout. More insured pets can change the conversation about the treatment estimate, the insurance claim steps, and the chance that a client accepts diagnostics or treatment.

The operating question is whether insurance makes checkout easier. Clinics should track claim delays, direct pay use, and treatment acceptance among insured clients.

CONFIDENCE

High — supported by a U.S. Securities and Exchange Commission (SEC)-hosted company earnings release; local insured pet mix remains practice specific.

ACTIONS

Independent veterinary practices

  • Track insured client treatment acceptance weekly.
  • Review direct pay checkout steps this month.

Corporate veterinary groups and clinic consolidators

  • Compare insured pet mix by site monthly.
  • Standardize insurance documentation steps within 30 days.

Distributors, e-retail and home delivery providers

  • Track refills from insured clients monthly.
  • Review refill support for insured clients with clinic partners this quarter.

Manufacturers and commercial operators

  • Review demand in accounts with a high insured pet share this quarter.
  • Prepare insurer-neutral value materials before the next account review.

3. PetSmart Charities funding puts payment plans at checkout

OBSERVED

PetSmart Charities reported on May 5, 2026 that it had deployed $61 million under its veterinary access-to-care commitment. It said Accelerator Grants had supported 51 low-cost nonprofit veterinary clinics. It also said more than 819,000 pets had received reduced-cost care since January 2023. PetSmart Charities also said it funded a payment plan pilot aimed at reducing financial barriers at the point of care. 3

VIEWPOINT

This puts more focus on the checkout, where a client decides whether to approve, delay, or decline recommended care.

The pressure point is how clearly teams explain payment options. Operators should track declined care cases, payment plan use, and referrals to lower-cost care options while keeping the medical recommendation clear.

CONFIDENCE

High — supported by an official PetSmart Charities release; broader replication across markets remains open.

ACTIONS

Independent veterinary practices

  • Track declined care cases weekly.
  • Review payment option scripts this week.

Corporate veterinary groups and clinic consolidators

  • Compare declined care trends by region monthly.
  • Standardize payment option training within 30 days.

Distributors, e-retail and home delivery providers

  • Monitor refills delayed after cost objections monthly.
  • Review follow-up steps for delayed refills this quarter.

Manufacturers and commercial operators

  • Review demand in products often tied to cost concerns this quarter.
  • Prepare cost and refill completion evidence for field teams this month.

4. Boehringer Ingelheim and Eko bring AI murmur detection into exams

OBSERVED

Eko Health said on April 29, 2026 that Boehringer Ingelheim and Eko launched Eko Vet+ with CANINEBEAT AI for canine heart murmur detection, visualization, and grading. Eko said the algorithm was trained and validated on more than 4,000 annotated canine heart sound recordings. Eko also said the tool has begun introduction in the United States and United Kingdom and that veterinarians retain clinical judgment. 4

VIEWPOINT

This brings decision support, meaning software that helps assess a finding, into a routine exam step. The tool may identify a concern earlier in the visit and support owner education, follow-up diagnostics, monitoring, or referral.

The pressure point is where the tool fits in the exam. Practices should decide who records, reviews, documents, and explains the result before adding AI assisted heart sound checks to routine canine exams.

CONFIDENCE

High — supported by an Eko press release with product scope and launch geography; adoption speed remains open.

ACTIONS

Independent veterinary practices

  • Review the canine heart check workflow this month.
  • Track follow-up diagnostics after murmur findings weekly.

Corporate veterinary groups and clinic consolidators

  • Set AI tool evaluation criteria within 30 days.
  • Compare referral flow after trial use of the heart check tool monthly.

Distributors, e-retail and home delivery providers

  • Watch demand for connected stethoscope and exam devices this quarter.
  • Track new cardiac medication starts monthly where data is available.

Manufacturers and commercial operators

  • Review current partnerships with connected exam device vendors this quarter.
  • Update cardiac care materials for field teams before the next call cycle.

5. VMG and AAHA update financial benchmarking structure

OBSERVED

Veterinary Management Groups (VMG) and the American Animal Hospital Association (AAHA) released an updated VMG/AAHA Chart of Accounts on April 30, 2026. The Chart of Accounts is a standard list for coding revenue and expenses. AAHA said the updated framework is designed to support more consistent revenue and expense reporting. It includes revised categories and definitions aligned to current practice models. 5

VIEWPOINT

This is a signal about how practices organize financial data. More standard revenue and expense categories can make practice revenue and cost performance easier to compare across services, locations, and similar practices.

The key step is how revenue and expenses are coded. Practices and groups should decide how quickly they can map current categories to the updated framework.

CONFIDENCE

High — supported by an AAHA publication and resource page; adoption pace across practices remains open.

ACTIONS

Independent veterinary practices

  • Map revenue categories to the update this month.
  • Review expense classifications before the next close.

Corporate veterinary groups and clinic consolidators

  • Compare revenue and expense mapping across sites within 30 days.
  • Standardize definitions used in benchmark reports this quarter.

Distributors, e-retail and home delivery providers

  • Watch clinic demand for support with finance reports this quarter.
  • Track reporting requests from practice partners monthly.

Manufacturers and commercial operators

  • Align field team materials with practice benchmarks this quarter.
  • Review how product categories appear in reports before account reviews.

Early watch items

1. Supplement and therapeutic nutrition repeat purchases may face more proof checks

OBSERVED

Petfood Industry reported on May 5, 2026 that the National Animal Supplement Council unveiled a proposed Animal Health Supplement Act. The reported proposal would create a federal animal health supplement category. It would limit products to claims about supporting normal body structure or function. It would prohibit claims to treat or prevent disease. It would also create a national product listing system, set manufacturing quality standards, require reporting of health or safety complaints, and override conflicting state requirements. 6

Petfood Industry reported on May 1, 2026 that Fera Pets expanded into Petco stores nationwide and Petco.com with a selected supplement assortment. Reported products included hip and joint, multivitamin, cardiac support, fiber support, and probiotic products. 7

Colgate-Palmolive reported that Hill’s Pet Nutrition net sales were $1.194 billion in Q1 2026, up 6.7%. It also said Hill’s sales growth using Colgate-Palmolive’s organic measure was led by therapeutic and wellness categories. 8

SPECULATIVE ASSESSMENT

These moves may point to more pressure around repeat supplement and therapeutic nutrition purchases. Retail and online access is expanding. At the same time, retailers and brands may face stronger pressure for proof, tighter product claims, product listing, and safety complaint processes.

The key step is the repeat purchase after a health recommendation. Clinics, retailers, home delivery providers, and manufacturers may need cleaner documentation on what the product claims, where it sells, and whether the next purchase stays with the clinic, retailer, or home delivery provider.

CONFIDENCE

Low — the events are real and connected, but behavior change in retailer requirements, clinic recommendations, and where repeat purchases go remains early.

WHAT WOULD CONFIRM THIS

  • Draft supplement bill language appears within 60 days.
  • Retailers request stronger claim support files this quarter.
  • More veterinarian founded supplement brands enter national retail.

WHAT WOULD RULE THIS OUT

  • The supplement proposal stalls before draft text.
  • Retail supplement proof requirements stay unchanged.
  • Clinic teams keep recommending the same supplement mix.

HOW TO PREPARE NOW

Independent veterinary practices

  • Review supplement recommendation language this month.
  • Track retail supplement questions weekly.

Corporate veterinary groups and clinic consolidators

  • Create one supplement proof checklist within 30 days.
  • Compare approved supplement lists by site this quarter.

Distributors, e-retail and home delivery providers

  • Review supplement product pages this month.
  • Track missing supplier documentation monthly.

Manufacturers and commercial operators

  • Assemble claim support files this quarter.
  • Review safety complaint processes before the next product review.

2. Senior cat care may add more products and refills

OBSERVED

The U.S. Food and Drug Administration (FDA) said on April 29, 2026 that it approved AMODIP, an amlodipine besylate chewable tablet, for control of systemic hypertension, or high blood pressure, in cats. FDA said AMODIP is the first FDA approved amlodipine product for veterinary use and the second FDA approved product for control of hypertension in cats. 9

Hill’s Pet Nutrition announced Prescription Diet Metabolic + j/d on April 30, 2026. Hill’s said the feline therapeutic diet, meaning a diet recommended for a health condition, combines weight and mobility support and is available through veterinarian recommendation. 10

Colgate-Palmolive reported that Hill’s Pet Nutrition net sales were $1.194 billion in Q1 2026, up 6.7%. It also said Hill’s sales growth using Colgate-Palmolive’s organic measure was led by therapeutic and wellness categories. 8

SPECULATIVE ASSESSMENT

These moves may point to more focus on senior cat chronic care. The mechanism is a more complete ongoing care path: screening, diagnosis, prescription therapy, therapeutic nutrition, follow-up, and repeat medication or diet orders.

The evidence supports continued monitoring. The product and approval events are clear, but uptake, clinic workflow change, and refill behavior are still unmeasured.

CONFIDENCE

Low — regulatory and product launch evidence is strong, but the broader senior cat commercial pattern needs adoption data.

WHAT WOULD CONFIRM THIS

  • More senior cat launches appear within 90 days.
  • Clinics add feline blood pressure screening prompts.
  • Groups standardize senior cat mobility and weight checks.
  • E-retailers add clearer for senior cat medications and diets.

WHAT WOULD RULE THIS OUT

  • AMODIP uptake stays limited to existing cases.
  • Senior cat exam workflows stay unchanged.
  • Therapeutic diet demand shows little growth in cat related orders.
  • Refill continue through existing substitute products or pharmacies.

HOW TO PREPARE NOW

Independent veterinary practices

  • Review senior cat exam prompts this month.
  • Track blood pressure and mobility discussions weekly.

Corporate veterinary groups and clinic consolidators

  • Compare how consistently sites use senior cat screening steps within 30 days.
  • Measure feline therapeutic diet starts monthly.

Distributors, e-retail and home delivery providers

  • Monitor inventory for senior cat chronic care monthly.
  • Review who handles cat medication refills this quarter.

Manufacturers and commercial operators

  • Review planned senior cat launches this quarter.
  • Prepare feline chronic care materials for field teams this month.

Methodology and governance

This PULSE Edition covers developments posted or acted on from April 29 through May 6, 2026, using U.S. Eastern Time.

Observed statements are anchored to public sources and attributed subscriber reports cited below. Viewpoints are PETMETRIX assessments that interpret commercial implications for operators. Early watch items are early hypotheses. They are not yet strong enough for a full Signal, and they include what would confirm or rule out the pattern.

PETMETRIX PULSE commercial intelligence is provided for informational use and to support lawful, independent business decisions. It is not legal, clinical, reimbursement, accounting, or financial advice. Route legal, clinical, reimbursement, accounting, and financial decisions to qualified advisers. Respect for the veterinary-client-patient relationship is mandatory.

Terms of Service | Privacy Policy | Methodology and Data Disclaimer

Glossary

Adverse event reporting: Submitting an adverse event, product problem, or safety complaint to the product company, FDA, USDA, or another required reporting system.

Chart of accounts: A standard list of accounting codes used to classify revenue and expenses.

Confidence: PETMETRIX rating of the strength and consistency of a signal. It is expressed as High, Moderate, or Low and does not mean certainty.

Direct pay: Insurance payment workflow in which the insurer pays the veterinary team directly at checkout.

Evidence file: Documents, data, studies, labels, approved wording, and records kept to support a product, protocol, marketing, or clinical claim.

Observed: A statement anchored in an attributable source, for example a company announcement, regulator posting, publication, data release, or market report.

Organic growth: A company growth measure that removes items such as acquisitions, divestitures, currency changes, or other company-specific adjustments.

Outside lab: A laboratory outside the clinic that runs tests for the clinic.

Payment plan pilot: A test program that lets clients pay veterinary costs over time.

Speculative assessment: A forward-looking hypothesis based on early indicators, with criteria that would confirm or rule out the pattern.

Structure/function claim: A claim that a product supports normal body structure or function, without saying it diagnoses, treats, cures, or prevents disease.

Subscription enrolled pets: Pets enrolled in an insurer’s subscription products at the reporting date.

Systemic hypertension: High blood pressure throughout the body.

Therapeutic diet: A veterinary diet recommended for a specific health condition or clinical need.

Viewpoint: PETMETRIX interpretation of observed facts through a commercial lens.

References

  1. IDEXX Laboratories, Inc. “IDEXX Laboratories Announces First Quarter Results.” Form 8-K, Exhibit 99.1. U.S. Securities and Exchange Commission. May 5, 2026. https://www.sec.gov/Archives/edgar/data/874716/000110465926055203/tm2613510d1_ex99-1.htm
  2. Trupanion, Inc. “Trupanion Reports First Quarter 2026 Results.” Form 8-K, Exhibit 99.1. U.S. Securities and Exchange Commission. April 30, 2026. https://www.sec.gov/Archives/edgar/data/1371285/000137128526000098/ex991q12026.htm
  3. PetSmart Charities. “PetSmart Charities Expands Veterinary Care Access Effort, Advancing $100M Commitment.” May 5, 2026. https://petsmartcharities.org/press-releases/petsmart-charities-expands-veterinary-care-access-effort-advancing-100m-commitment
  4. Eko Health. “Boehringer Ingelheim and Eko Health Inc. Launch New AI-Based Solution That Detects Heart Murmurs in Dogs.” April 29, 2026. https://www.ekohealth.com/blogs/newsroom/ai-powered-canine-murmur-detection
  5. American Animal Hospital Association. “VMG, AAHA release updated VMG/AAHA Chart of Accounts.” April 30, 2026. https://www.aaha.org/trends-magazine/publications/aaha-vmg-release-updated-chart-of-accounts/
  6. Petfood Industry. “NASC proposes Animal Health Supplement Act for regulatory clarity.” May 5, 2026. https://www.petfoodindustry.com/pet-supplements-pro/nasc-regulatory-update/article/15823047/nasc-proposes-animal-health-supplement-act-for-regulatory-clarity
  7. Petfood Industry. “Fera Pets supplements expand into Petco stores nationwide.” May 1, 2026. https://www.petfoodindustry.com/pet-supplements-pro/supplements-supplier-brief/news/15823964/fera-pets-supplements-expand-into-petco-stores-nationwide
  8. Colgate-Palmolive Company. “Form 10-Q.” U.S. Securities and Exchange Commission. May 1, 2026. https://www.sec.gov/Archives/edgar/data/21665/000002166526000023/cl-20260331.htm
  9. U.S. Food and Drug Administration. “FDA Approves First Veterinary Amlodipine Product to Control Systemic Hypertension in Cats.” April 29, 2026. https://www.fda.gov/animal-veterinary/cvm-updates/fda-approves-first-veterinary-amlodipine-product-control-systemic-hypertension-cats
  10. Hill’s Pet Nutrition. “Hill’s Pet Nutrition Introduces Innovation to Support Feline Mobility and Weight Management.” April 30, 2026. https://www.prnewswire.com/news-releases/hills-pet-nutrition-introduces-innovation-to-support-feline-mobility-and-weight-management-302758110.html